PUQE-NCase-cohort Validation Study of Pregnancy Unique Questionnaire of Emesis (PUQE) in Norwegian
Data Collection
+ other Data
+ other Data
Collected from today forward - ProspectiveUrogenital Diseases+7
+ Female Urogenital Diseases and Pregnancy Complications
+ Pregnancy Complications
Case-Control
Comparing exposures between individuals with and without disease in order to identify potential risk factors.Summary
Study start date: May 1, 2013
Actual date on which the first participant was enrolled.This is a prospective case-control study validating Pregnancy Unique Questionnaire of Emesis (PUQE) in a Norwegian population. The questionnaire has been translated from English to Norwegian by authorized translators. The Norwegian questionnaire's title is Svangerskaps Utløst Kvalme Kvantifisering (SUKK). The Norwegian version has been independently back-translated to English. The back-translated version has been approved by the original author Gideon Koren. The primary objective is to evaluate if the questionnaire score is significantly different between a group of presumed healthy pregnant woman and a group of patients hospitalized with hyperemesis gravidarum. The women will also fill in a self-reported 24-hours nutritional intake diary and this will be related to the Pregnancy Unique Questionnaire of Emesis (PUQE)score. For patients hospitalized with hyperemesis gravidarum the Pregnancy Unique Questionnaire of Emesis (PUQE)score both at admission and discharge will be compared. Background clinical information for both groups at enrollment will be recorded as well as pregnancy outcome for woman and child. The study has been approved by the Institutional Board as well as the Norwegian Regional Ethical Committee (REK Norway). Women will be included after giving informed written consent. Data will be stored electronically, anonymised, at a designated research server in accordance with the institutional research rules. The sample size have been determined on basis of a similar study evaluating different nutritional status in emesis and hyperemesis patients, using 20 patients in each group. We aim to include 30 patients in each group. Patients with diagnose of Hyperemesis gravidarum admitted form 1st of May 2013 will be consecutively asked to participate. Control patients will be recruited by invitation at primary care facilities or private out-patient gynaecologists. Statistical analyses will be performed using Statistical Package for the Social Sciences (SPSS). Categorical variables will be compared using Chi-square test and continuous variables by non-parametric tests. Paired test will be used when comparing Pregnancy Unique Questionnaire of Emesis (PUQE)scores sequentially from admittance to discharge.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.69 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-Control
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 16 to 50 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: Pregnant healthy women (controls) Patients admitted to hospital for hyperemesis gravidarum Exclusion Criteria: Pregnancy duration at inclusion more than 16 weeks Unable to understand and read/write Norwegian Conditions other than hyperemesis leading to nausea/vomiting
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
Dpt. of Obstetrics and Gynaecology, Haukeland University Hospital
Bergen, NorwayOpen Dpt. of Obstetrics and Gynaecology, Haukeland University Hospital in Google MapsDpt Obstetrics Gynaecology, Stavanger University Hospital
Stavanger, Norway